MARSHALL WACE, LLP - KALVISTA PHARMACEUTICALS INC ownership

KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 76 filers reported holding KALVISTA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.7%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of KALVISTA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$496,176
+299.0%
51,524
+180.1%
0.00%
Q4 2022$124,357
-90.6%
18,396
-86.2%
0.00%
-100.0%
Q2 2022$1,316,000
+145.5%
133,687
+267.7%
0.00%
+200.0%
Q1 2022$536,000
+31.7%
36,359
+113.9%
0.00%
-50.0%
Q2 2021$407,000
-57.7%
16,996
-54.6%
0.00%
-50.0%
Q1 2021$962,000
+582.3%
37,443
+102.9%
0.00%
+300.0%
Q1 2020$141,000
-91.6%
18,454
-68.7%
0.00%
-87.5%
Q1 2019$1,686,00058,9040.01%
Other shareholders
KALVISTA PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Prosight Management, LP 589,270$8,686,0005.61%
GREAT POINT PARTNERS LLC 874,197$12,886,0003.11%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 383,233$10,805,0002.44%
Frazier Life Sciences Management, L.P. 1,572,192$23,174,0001.98%
TANG CAPITAL MANAGEMENT LLC 648,269$9,555,0001.91%
Deep Track Capital, LP 1,729,757$25,497,0001.64%
Vivo Capital, LLC 1,533,559$22,605,0001.56%
Monashee Investment Management LLC 264,111$3,893,0001.13%
COMMODORE CAPITAL LP 312,553$4,607,0001.03%
SUVRETTA CAPITAL MANAGEMENT, LLC 1,746,300$25,740,0000.79%
View complete list of KALVISTA PHARMACEUTICALS INC shareholders